跳至主要内容
临床试验/NCT07780019
NCT07780019进行中(未招募)不适用

Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Symptom severity of uterine fibroids and quality of life

研究概览

简要总结

This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 56 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • symptomatic fibroids
  • premenopausal status
  • acceptable risks for general anestesia or sedation
  • willing to undergo mwa treatment and participate in the study

排除标准

  • postmenopausal status
  • bleeding disorder with increased risk of bleeding

研究组 & 干预措施

patients with symptomatic uterine fibroids

Patients with symptomatic uterine fibroids, who will undergo microwave ablation of fibroids as a clinical treatment are recruited in this study.

干预措施: microwave ablation (Procedure)

结局指标

主要结局

Symptom severity of uterine fibroids and quality of life

时间窗: 12 months

Score of validated form Uterine Fibroid symptom - Quality of life questinnaire. minimum 0, maximum 100 where higher scores indicate higher symptom severity

suitability of mwa for general fibroid population

时间窗: 12 months

objective and subjective outcome of mwa in different fibroid types, sizes and locations

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kirsi Joronen

Principal Investigator

Turku University Hospital

研究点 (1)

Loading locations...

相似试验